Search research articles
Contact Us
Filters
Showing results (81-90 of 90) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 90 results.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 11, 2021
Correction to: EWSR1-PATZ1-rearranged sarcoma: a report of nine cases of spindle and round cell neoplasms with predilection for thoracoabdominal soft tissues and frequent expression of neural and skeletal muscle markers
Michael Michal, Brian P Rubin, Abbas Agaimy, et al.
Virchows Archiv : an International Journal of Pathology
|
December 6, 2024
YAP1::KMT2A-rearranged sarcomas harbor a unique methylation profile and are distinct from sclerosing epithelioid fibrosarcoma and low-grade fibromyxoid sarcoma
Laura M Warmke, Baptiste Ameline, Karen J Fritchie, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 12, 2025
Prioritization of novel agents for further investigation in pediatric non-rhabdomyosarcoma soft tissue sarcomas: A report from the Children's Oncology Group
Jacquelyn N Crane, David P Douglass, Sapna Oberoi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 10, 2025
Malignant Chondroblastoma: An Epigenetically Distinct Subtype of Chondroblastoma With a Predilection for the Skeletally Mature
Karen Fritchie, Baptiste Ameline, Vanghelita Andrei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 31, 2023
Outcomes After Preoperative Chemoradiation With or Without Pazopanib in Non-Rhabdomyosarcoma Soft Tissue Sarcoma: A Report From Children's Oncology Group and NRG Oncology
Aaron R Weiss, Yen-Lin Chen, Thomas J Scharschmidt, et al.
Journal of the National Cancer Institute
|
August 12, 2025
Childhood Cancer Data Initiative: Expanded access to tumor molecular profiling for children, adolescents, and young adults
Joseph Flores-Toro, Subhashini Jagu, Malcolm Smith, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 27, 2024
Optimizing Ewing Sarcoma and Osteosarcoma Biopsy Acquisition: A Children's Oncology Group Bone Tumor Committee Consensus Statement
Matthew S Dietz, Alyaa Al-Ibraheemi, Jessica L Davis, et al.
Frontiers in Pharmacology
|
April 29, 2024
Early, precise, and safe clinical evaluation of the pharmacodynamic effects of novel agents in the intact human tumor microenvironment
Kenneth R Gundle, Karthik Rajasekaran, Jeffrey Houlton, et al.
The Lancet. Oncology
|
July 24, 2020
Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial
Aaron R Weiss, Yen-Lin Chen, Thomas J Scharschmidt, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 12, 2026
Pleomorphic rhabdomyosarcoma, outcomes of patients with advanced disease treated with systemic agents: Retrospective study from the global pushing ultra-rare sarcomas towards hope (PUSH) consortium
Giacomo G Baldi, Claudia Giani, Silva Ljevar, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 90) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 90 results.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 11, 2021
Correction to: EWSR1-PATZ1-rearranged sarcoma: a report of nine cases of spindle and round cell neoplasms with predilection for thoracoabdominal soft tissues and frequent expression of neural and skeletal muscle markers
Michael Michal, Brian P Rubin, Abbas Agaimy, et al.
Virchows Archiv : an International Journal of Pathology
|
December 6, 2024
YAP1::KMT2A-rearranged sarcomas harbor a unique methylation profile and are distinct from sclerosing epithelioid fibrosarcoma and low-grade fibromyxoid sarcoma
Laura M Warmke, Baptiste Ameline, Karen J Fritchie, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 12, 2025
Prioritization of novel agents for further investigation in pediatric non-rhabdomyosarcoma soft tissue sarcomas: A report from the Children's Oncology Group
Jacquelyn N Crane, David P Douglass, Sapna Oberoi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 10, 2025
Malignant Chondroblastoma: An Epigenetically Distinct Subtype of Chondroblastoma With a Predilection for the Skeletally Mature
Karen Fritchie, Baptiste Ameline, Vanghelita Andrei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 31, 2023
Outcomes After Preoperative Chemoradiation With or Without Pazopanib in Non-Rhabdomyosarcoma Soft Tissue Sarcoma: A Report From Children's Oncology Group and NRG Oncology
Aaron R Weiss, Yen-Lin Chen, Thomas J Scharschmidt, et al.
Journal of the National Cancer Institute
|
August 12, 2025
Childhood Cancer Data Initiative: Expanded access to tumor molecular profiling for children, adolescents, and young adults
Joseph Flores-Toro, Subhashini Jagu, Malcolm Smith, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 27, 2024
Optimizing Ewing Sarcoma and Osteosarcoma Biopsy Acquisition: A Children's Oncology Group Bone Tumor Committee Consensus Statement
Matthew S Dietz, Alyaa Al-Ibraheemi, Jessica L Davis, et al.
Frontiers in Pharmacology
|
April 29, 2024
Early, precise, and safe clinical evaluation of the pharmacodynamic effects of novel agents in the intact human tumor microenvironment
Kenneth R Gundle, Karthik Rajasekaran, Jeffrey Houlton, et al.
The Lancet. Oncology
|
July 24, 2020
Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial
Aaron R Weiss, Yen-Lin Chen, Thomas J Scharschmidt, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 12, 2026
Pleomorphic rhabdomyosarcoma, outcomes of patients with advanced disease treated with systemic agents: Retrospective study from the global pushing ultra-rare sarcomas towards hope (PUSH) consortium
Giacomo G Baldi, Claudia Giani, Silva Ljevar, et al.
Page
of 9